Computational Drug Repurposing of a Ketamine–Methylphenidate Conjugate for Targeting GLIPR1 in Human Glioma: Computational Targeting of GLIPR1 Using a Ketamine–Methylphenidate Conjugate. Futuristic Biotechnology, v. 5, n. 4, p. 67–72, 31 Dec.2025.